Furthermore, these CD4CAR-redirected effector cells exhibited profound killing capacity against CD4-positive AML cells in vivo, and efficiently controlled leukemia progression and prolonged survival in xenograft mouse models. The gene discussed is CD4; the disease is leukemia.